Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Bright Minds Biosciences Inc

DRUG ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Small Cap Analyst: BUY

Last Close

$79.49

▲ +3.20%

Market Cap $782.24M · Vol 23.33K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$782.24M

Small Cap

Div Yield

N/A

EPS Growth

-210.08%

YoY

RSI (14)

49.04

Momentum

Beta

-5.07

vs Market

52W High

$123.75

35.77% below

52W Low

$38.23

107.93% above

Volume

23.33K

Avg 39.51K

P/B

7.85

Price-to-book

ROE

N/A

Return on equity

Free Float

87.12%

Public shares

Shariah Compliance8 STANDARDS

✗ Bright Minds Biosciences Inc (DRUG) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does DRUG pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-5.41%

+11.44%

-4.80%

-11.68%

YTD

+1.86%

+90.62%

+3,005.08%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-8,785,453.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-27.02% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	7.85
P/FCF	N/A
EPS Growth	-210.08%
Outstanding Shares	9.86M

Technical Indicators

50-Day SMA	$73.00
200-Day SMA	$77.34
RSI (14)	49.04
Beta	-5.07
52-Week High	$123.75
52-Week Low	$38.23

Volume Today	23.33K
Avg Daily Volume (30D)	39.51K
Relative Volume	0.59x
Volatility (10D)	55.88
Volatility (30D)	47.22
Free Float	87.12%

Analyst Consensus

BUY

Current Price $79.49

Mean Target $148.56

52W Low$38.23 52W High$123.75

Current

Target

$38.23 $123.75

Current Analyst target

+86.89% upside potential · 7 analysts

Identifiers

ExchangeNasdaq

FIGIBBG00Z61F382

ISINCA10919W4056

CountryUnited States of America

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateDec 21, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LONN.S Lonza Group AG +1.02% ONC BeOne Medicines AG +1.18% RVMD Revolution Medicines Inc -0.09% 068270.KS Celltrion Inc -2.27% ABVX Abivax SA +1.53%

Company Profile

Bright Minds Biosciences Inc. is a biotechnology company, which is engaged in developing treatments for patients with neurological and psychiatric disorders. The Company is focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant epilepsy, depression, and other central nervous system (CNS) disorders. Its Serotonin (5-HT) is a neurotransmitter in the brain and modulates many biological functions. Dysfunction of serotonin receptors, transporters, and associated neurocircuits is fundamental to many diseases including epilepsies and neuro psychiatric. Its pipeline includes BMB-101, BMB-xxx, BMB-201, and BMB-202. The Company has a portfolio of patented, selective serotonin (5-HT2C, 5-HT2A and 5-HT2C/A-receptor subtypes) agonists that were identified by using high-throughput screening methods in combination with advanced molecular modeling techniques to interrogate the interaction between the drug and its targeted receptors to increase downstream signaling.